Overview
Cedar Lifetech Ventures is a Singapore-headquartered Variable Capital Company (VCC) fund focused on cross-border investment and industrial value creation in healthcare and life sciences. We lead the introduction into Singapore of high-quality listed pharmaceutical companies from the China–Singapore Suzhou Industrial Park, alongside globally leading innovation technologies—supporting them in establishing overseas innovation centres, international headquarters, and localised brands.
Our operating model aligns closely with the Singapore Economic Development Board's (EDB) Singapore +1 ambition: building intellectual property, core teams, and manufacturing capability in Singapore, then scaling outward into ASEAN and global markets.
As a VCC, we operate an umbrella structure that allows investors to participate through distinct sub-funds, each with its own mandate and strategy. The assets and liabilities of each sub-fund are ring-fenced by statute—preventing cross-contamination of risk—while liquidity and redemption terms are tailored to each fund's mission. The result: precise exposure, with risk and return cleanly aligned to your objectives.
Our Edge ("Singapore +1")
We build our platform around policy alignment with the EDB's Singapore+1 (SG+) vision—translating national-level tailwinds and deep industrial capability into compounding, sustainable returns.
Our differentiation operates on three levels:
-
Industrial execution. Beyond capital, we orchestrate resources, market entry, and team building—helping companies anchor in Singapore quickly, localise efficiently, and accelerate into ASEAN using Singapore as their base.
-
Ecosystem gravity. Through partnerships with anchor enterprises and ecosystem allies, we generate a gravitational pull on high-quality healthcare assets, drawing them into Singapore and reinforcing its position as Asia's hub for advanced intelligent manufacturing and medical technology.
-
Structural flexibility. Our VCC vehicle further amplifies SG+ synergies by standing up new, statutorily ring-fenced sub-funds opportunistically—preserving strategy purity while allowing investors to select the risk-return and liquidity profile that fits them best.
Our Partners
We partner with established, financially robust technology companies with stable cash flows—and with anchor enterprises capable of rapid market entry and dividend generation. Our ideal counterparts have completed R&D, secured the relevant approvals and registrations, achieved commercialisation, earned global recognition, and continue to invest in technology iteration.
We support our partners in localising rights, teams, and intellectual property in Singapore, structuring financing accordingly, and accelerating entry into ASEAN—expanding revenue footprint and growth momentum.
